Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: Tuberculosis (mmu05152)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
1500003O
03Rik
KLA  ATP  ATP+KLA
 NM_019769 RIKEN cDNA 1500003O03 gene (1500003O03Rik), mRNA [NM_019769] KLA .92 .89 .89 .86 .85 .92 1.08
ATP 1.01 1.16 1.16 1.53 1.70 3.33 2.09
KLA/ATP .89 .97 .93 1.17 1.19 2.86 2.57
2010110P
09Rik
KLA  ATP  ATP+KLA
 NM_027363 RIKEN cDNA 2010110P09 gene (2010110P09Rik), mRNA [NM_027363] KLA .99 .98 1.02 .99 .94 1.01 1.01
ATP 1.04 1.05 .97 1.05 .95 .98 .95
KLA/ATP .93 1.00 1.02 .97 1.01 .96 .97
AI851602
KLA  ATP  ATP+KLA
 AI851602 gb|UI-M-BH0-ain-a-06-0-UI.s1 NIH_BMAP_M_S1 Mus musculus cDNA clone UI-M-BH0-ain-a-06-0-UI 3. [AI851602] KLA .92 .88 .85 1.01 .98 .91 .98
ATP 1.06 1.14 .94 1.07 1.23 1.18 .80
KLA/ATP .87 .89 .87 .97 1.34 .96 .85
AK036998
KLA  ATP  ATP+KLA
 AK036998 adult female vagina cDNA, RIKEN full-length enriched library, clone:9930034M05 product:unclassifiable, full insert sequence. [AK036998] KLA 1.43 1.09 .89 .79 .96 .97 .71
ATP 1.04 1.04 .71 .64 .90 .82 .82
KLA/ATP 1.34 1.23 1.01 .89 1.10 .82 .75
Akt1
KLA  ATP  ATP+KLA
 NM_009652 thymoma viral proto-oncogene 1 (Akt1), mRNA [NM_009652] KLA .80 .80 .75 .75 .71 .70 .82
ATP 1.00 1.02 .76 .85 .76 .68 .84
KLA/ATP .82 .80 .64 .68 .67 .61 .72
Akt2
KLA  ATP  ATP+KLA
 NM_007434 thymoma viral proto-oncogene 2 (Akt2), transcript variant 2, mRNA [NM_007434] KLA 1.45 1.49 1.81 1.61 1.83 1.17 .92
ATP 1.12 1.12 1.00 1.28 1.20 .94 1.06
KLA/ATP 1.48 1.70 1.69 1.58 1.57 1.32 1.27
Akt3
KLA  ATP  ATP+KLA
 NM_011785 thymoma viral proto-oncogene 3 (Akt3), mRNA [NM_011785] KLA 3.42 3.45 5.31 5.16 4.65 3.80 2.12
ATP 1.12 1.22 1.10 1.37 1.02 1.11 1.56
KLA/ATP 3.72 4.17 4.62 4.64 2.74 2.05 3.82
Apaf1
KLA  ATP  ATP+KLA
 NM_001042558 apoptotic peptidase activating factor 1 (Apaf1), transcript variant 1, mRNA [NM_001042558] KLA 2.92 2.81 3.22 2.74 2.42 1.74 1.40
ATP 1.05 .99 .87 .81 1.61 2.03 1.46
KLA/ATP 2.90 2.78 2.01 1.69 1.56 2.77 2.73
Arhgef12
KLA  ATP  ATP+KLA
 NM_027144 Rho guanine nucleotide exchange factor (GEF) 12 (Arhgef12), mRNA [NM_027144] KLA 1.01 .94 .89 .87 .84 .81 .80
ATP 1.05 .94 1.09 .77 .60 .86 .78
KLA/ATP .93 .88 .86 .70 .52 .66 .58
Atp6ap1
KLA  ATP  ATP+KLA
 NM_018794 ATPase, H+ transporting, lysosomal accessory protein 1 (Atp6ap1), mRNA [NM_018794] KLA .73 .83 .89 .71 .74 .71 1.06
ATP 1.05 1.08 .94 1.12 .99 .79 1.07
KLA/ATP .90 .81 .72 .84 .62 .64 .97
Atp6v0a1
KLA  ATP  ATP+KLA
 AK045877 adult male corpora quadrigemina cDNA, RIKEN full-length enriched library, clone:B230316H04 product:unclassifiable, full insert sequence [AK045877] KLA .65 .64 .58 .48 .57 .46 .29
ATP .64 .28 .48 .28 .45 .30 .91
KLA/ATP .51 .26 .37 .31 .54 .45 .63
Atp6v0a1
KLA  ATP  ATP+KLA
 NM_016920 ATPase, H+ transporting, lysosomal V0 subunit A1 (Atp6v0a1), mRNA [NM_016920] KLA .88 .91 .88 .80 .66 .52 .45
ATP 1.05 1.22 .91 1.05 .58 .40 1.46
KLA/ATP .97 1.04 .80 .89 .55 .43 .75
Atp6v0a2
KLA  ATP  ATP+KLA
 AK160318 16 days embryo lung cDNA, RIKEN full-length enriched library, clone:8430408C20 product:unclassifiable, full insert sequence [AK160318] KLA 1.21 1.13 1.18 1.30 1.39 1.58 1.38
ATP 1.10 .94 .55 .35 .72 .96 .84
KLA/ATP 1.12 1.08 .82 .54 .81 1.05 .59
Atp6v0a2
KLA  ATP  ATP+KLA
 BC112905 ATPase, H+ transporting, lysosomal V0 subunit A2, mRNA (cDNA clone MGC:118073 IMAGE:3670722), complete cds [BC112905] KLA 1.65 1.66 1.74 2.07 1.97 2.78 2.71
ATP .88 .61 .53 .30 .38 1.26 2.12
KLA/ATP 1.38 1.29 .91 .62 .59 1.36 2.13
Atp6v0a2
KLA  ATP  ATP+KLA
 NM_011596 ATPase, H+ transporting, lysosomal V0 subunit A2 (Atp6v0a2), mRNA [NM_011596] KLA 2.26 2.07 2.01 2.71 2.48 3.69 2.76
ATP .79 .64 .62 .42 .62 2.31 3.11
KLA/ATP 1.69 1.57 1.47 .90 1.06 2.56 4.84
Atp6v0a4
KLA  ATP  ATP+KLA
 NM_080467 ATPase, H+ transporting, lysosomal V0 subunit A4 (Atp6v0a4), mRNA [NM_080467] KLA 1.01 1.00 .99 1.03 1.01 1.02 .98
ATP 1.02 1.05 .93 1.03 1.05 1.01 .97
KLA/ATP 1.02 .94 1.00 .99 1.00 1.01 1.03
Atp6v0b
KLA  ATP  ATP+KLA
 NM_033617 ATPase, H+ transporting, lysosomal V0 subunit B (Atp6v0b), mRNA [NM_033617] KLA .91 1.00 1.07 .81 1.25 1.34 1.44
ATP 1.12 1.33 .80 1.41 1.47 1.67 1.77
KLA/ATP 1.20 1.16 .62 1.28 1.01 1.77 2.37
Atp6v0c
KLA  ATP  ATP+KLA
 NM_009729 ATPase, H+ transporting, lysosomal V0 subunit C (Atp6v0c), mRNA [NM_009729] KLA .89 .98 1.05 .90 1.18 1.38 1.52
ATP 1.07 1.28 .93 1.66 1.48 1.35 2.35
KLA/ATP 1.10 1.12 .67 1.50 1.18 1.66 2.51
Atp6v0d1
KLA  ATP  ATP+KLA
 NM_013477 ATPase, H+ transporting, lysosomal V0 subunit D1 (Atp6v0d1), mRNA [NM_013477] KLA .84 .85 .94 .79 1.10 1.24 1.27
ATP 1.18 1.48 .94 1.40 1.12 .75 1.85
KLA/ATP 1.05 1.06 .59 1.06 .83 .85 1.96
Atp6v0d2
KLA  ATP  ATP+KLA
 NM_175406 ATPase, H+ transporting, lysosomal V0 subunit D2 (Atp6v0d2), mRNA [NM_175406] KLA .77 .72 .64 .54 .43 .27 .18
ATP 1.19 1.35 1.06 1.47 1.46 .79 .96
KLA/ATP .78 .95 .63 1.12 1.21 1.01 .50
Atp6v1h
KLA  ATP  ATP+KLA
 AK081492 16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130021C16 product:hypothetical V-ATPase subunit H containing protein, full insert sequence. [AK081492] KLA 1.09 .98 .77 .93 1.08 1.00 1.10
ATP 1.16 1.43 2.03 3.91 3.02 1.23 1.46
KLA/ATP 1.02 .98 1.06 2.30 2.07 1.28 1.06
Atp6v1h
KLA  ATP  ATP+KLA
 NM_133826 ATPase, H+ transporting, lysosomal V1 subunit H (Atp6v1h), mRNA [NM_133826] KLA 1.13 1.15 1.12 1.05 1.05 .96 1.20
ATP 1.04 1.04 .86 1.06 2.07 2.38 1.90
KLA/ATP 1.14 1.17 .98 1.09 1.55 2.06 1.29
BB229853
KLA  ATP  ATP+KLA
 BB229853 gb|BB229853 RIKEN full-length enriched, 3 days neonate thymus Mus musculus cDNA clone A630023O21 3. [BB229853] KLA 6.32 5.94 6.13 6.41 7.39 12.33 6.08
ATP .39 .24 .33 .38 1.18 5.75 2.85
KLA/ATP 2.27 2.02 3.25 4.04 7.11 10.22 13.93
Bad
KLA  ATP  ATP+KLA
 AK029400 0 day neonate head cDNA, RIKEN full-length enriched library, clone:4833429M11 product:Bcl-associated death promoter, full insert sequence. [AK029400] KLA 1.15 1.22 1.26 1.31 1.40 1.67 1.59
ATP .95 1.06 1.12 1.06 .78 .89 1.27
KLA/ATP 1.25 1.39 1.33 1.29 1.11 .91 1.38
Bax
KLA  ATP  ATP+KLA
 NM_007527 Bcl2-associated X protein (Bax), mRNA [NM_007527] KLA 1.08 1.14 1.10 1.14 1.17 1.06 .92
ATP 1.06 1.05 1.02 1.25 1.26 .90 .86
KLA/ATP 1.11 1.19 1.30 1.34 1.34 .87 .71
Bcl10
KLA  ATP  ATP+KLA
 AK080820 adult male corpora quadrigemina cDNA, RIKEN full-length enriched library, clone:B230313B18 product:unclassifiable, full insert sequence [AK080820] KLA 1.44 1.52 1.23 1.38 1.54 1.25 1.08
ATP 1.31 1.35 1.59 1.40 3.05 2.29 .90
KLA/ATP 1.58 2.14 1.93 1.47 2.94 1.95 1.33
Bcl10
KLA  ATP  ATP+KLA
 NM_009740 B-cell leukemia/lymphoma 10 (Bcl10), mRNA [NM_009740] KLA 1.63 1.57 1.42 1.42 1.52 1.04 1.14
ATP 1.10 1.12 1.04 1.06 1.97 2.63 1.15
KLA/ATP 1.40 1.58 1.36 1.27 1.54 1.87 1.51
Bcl2
KLA  ATP  ATP+KLA
 NM_009741 B-cell leukemia/lymphoma 2 (Bcl2), transcript variant 1, mRNA [NM_009741] KLA .30 .26 .25 .25 .34 .38 .26
ATP .97 .89 1.50 1.04 .99 .29 .52
KLA/ATP .28 .26 .40 .33 .62 .29 .12
Bcl2
KLA  ATP  ATP+KLA
 NM_177410 B-cell leukemia/lymphoma 2 (Bcl2), transcript variant 2, mRNA [NM_177410] KLA .33 .33 .37 .42 .49 .46 .39
ATP 1.07 1.12 1.22 1.56 1.00 .38 .76
KLA/ATP .35 .34 .54 .89 .76 .36 .23
Bid
KLA  ATP  ATP+KLA
 NM_007544 BH3 interacting domain death agonist (Bid), mRNA [NM_007544] KLA 1.03 1.08 1.09 1.14 1.01 .99 .68
ATP 1.06 1.11 .97 .89 1.04 1.17 1.08
KLA/ATP .88 1.09 .92 1.06 1.16 1.28 1.56
C3
KLA  ATP  ATP+KLA
 NM_009778 complement component 3 (C3), mRNA [NM_009778] KLA 28.58 25.57 24.39 27.34 23.38 23.21 18.10
ATP 1.04 .93 1.21 1.90 2.80 5.74 12.19
KLA/ATP 27.04 26.10 33.29 23.09 25.65 23.77 40.22
Calm1
KLA  ATP  ATP+KLA
 NM_009790 calmodulin 1 (Calm1), mRNA [NM_009790] KLA 1.20 1.26 1.30 1.06 1.16 1.09 1.18
ATP 1.07 1.20 1.00 1.29 .99 .64 .58
KLA/ATP 1.31 1.31 .93 1.31 .97 .83 .59
Calm2
KLA  ATP  ATP+KLA
 NM_007589 calmodulin 2 (Calm2), mRNA [NM_007589] KLA .79 .81 .71 .67 .54 .45 .64
ATP .99 1.03 1.04 .93 .82 .52 .76
KLA/ATP .76 .78 .76 .77 .73 .47 .42
Calm3
KLA  ATP  ATP+KLA
 NM_007590 calmodulin 3 (Calm3), mRNA [NM_007590] KLA .95 .96 .93 1.03 1.05 1.08 1.00
ATP .93 .96 .99 .97 .93 .84 .72
KLA/ATP .89 .93 .90 .91 1.02 .98 .70
Calm4
KLA  ATP  ATP+KLA
 NM_020036 calmodulin 4 (Calm4), mRNA [NM_020036] KLA 1.02 .96 1.05 1.00 .99 1.00 1.01
ATP 1.10 1.05 1.03 1.01 .94 .98 .98
KLA/ATP .99 1.12 1.01 1.03 .98 1.07 1.02
Calm5
KLA  ATP  ATP+KLA
 NM_001008706 calmodulin 5 (Calm5), mRNA [NM_001008706] KLA 1.02 1.11 .99 .98 1.07 1.01 1.09
ATP 1.07 1.05 1.04 1.04 1.01 1.04 .99
KLA/ATP 1.00 1.00 .97 1.07 1.00 1.07 .98
Calml3
KLA  ATP  ATP+KLA
 NM_027416 calmodulin-like 3 (Calml3), mRNA [NM_027416] KLA 1.01 .95 1.05 .91 1.01 .98 .89
ATP .91 1.05 1.04 1.01 .93 1.07 .99
KLA/ATP 1.01 .96 .97 .96 .97 .92 .99
Camk2a
KLA  ATP  ATP+KLA
 NM_177407 calcium/calmodulin-dependent protein kinase II alpha (Camk2a), transcript variant 2, mRNA [NM_177407] KLA .98 .97 .98 .95 .97 1.02 .97
ATP .98 1.11 1.02 .89 .94 .89 .82
KLA/ATP .99 .95 1.02 .88 .88 .87 .87
Camk2b
KLA  ATP  ATP+KLA
 NM_007595 calcium/calmodulin-dependent protein kinase II, beta (Camk2b), mRNA [NM_007595] KLA 1.09 1.28 1.42 1.41 1.37 1.24 .68
ATP .94 .87 .95 .91 .67 .44 .48
KLA/ATP 1.16 1.24 1.40 1.13 1.14 .81 .49
Camk2d
KLA  ATP  ATP+KLA
 AK032524 adult male olfactory brain cDNA, RIKEN full-length enriched library, clone:6430579P05 product:calcium/calmodulin-dependent protein kinase II, delta, full insert sequence. [AK032524] KLA 1.31 1.45 1.42 1.21 1.34 1.18 1.16
ATP 1.04 1.29 1.39 1.24 .94 .91 1.22
KLA/ATP 1.46 1.64 1.42 1.24 1.00 .93 1.10
Camk2d
KLA  ATP  ATP+KLA
 NM_001025439 calcium/calmodulin-dependent protein kinase II, delta (Camk2d), transcript variant 1, mRNA [NM_001025439] KLA 1.76 1.75 1.72 1.89 1.47 1.55 1.24
ATP 1.06 1.06 .93 1.01 1.22 .98 2.28
KLA/ATP 1.84 1.78 1.40 1.57 1.07 .60 1.97
Camk2g
KLA  ATP  ATP+KLA
 NM_178597 calcium/calmodulin-dependent protein kinase II gamma (Camk2g), transcript variant 1, mRNA [NM_178597] KLA .23 .24 .23 .44 .70 .73 .70
ATP .91 .85 1.07 .86 .58 .59 .95
KLA/ATP .22 .20 .35 .25 .54 .59 .71
Camp
KLA  ATP  ATP+KLA
 NM_009921 cathelicidin antimicrobial peptide (Camp), mRNA [NM_009921] KLA 2.06 1.98 2.14 1.70 1.91 1.76 2.16
ATP 1.37 1.37 1.44 1.73 1.80 1.62 1.27
KLA/ATP 2.03 2.12 2.47 2.63 2.16 1.58 1.90
Casp3
KLA  ATP  ATP+KLA
 NM_009810 caspase 3 (Casp3), mRNA [NM_009810] KLA 1.66 1.94 2.47 2.61 3.01 2.96 1.44
ATP .90 .99 1.17 1.30 1.01 1.17 .86
KLA/ATP 1.55 1.87 2.40 2.35 2.27 2.84 2.52
Casp3
KLA  ATP  ATP+KLA
 U49929 ICE-like cysteine protease (Lice) mRNA, complete cds. [U49929] KLA 1.71 1.87 2.69 3.11 3.64 3.42 1.52
ATP 1.04 1.07 1.16 1.34 .98 1.27 .86
KLA/ATP 1.80 1.96 2.46 2.91 2.50 3.24 3.10
Casp8
KLA  ATP  ATP+KLA
 NM_009812 caspase 8 (Casp8), transcript variant 1, mRNA [NM_009812] KLA 2.41 2.53 3.20 3.26 2.75 2.78 1.57
ATP .91 .96 .66 .67 .54 1.53 1.52
KLA/ATP 2.47 2.52 2.08 2.41 1.41 2.50 2.77
Casp9
KLA  ATP  ATP+KLA
 NM_015733 caspase 9 (Casp9), mRNA [NM_015733] KLA .31 .31 .40 .66 .89 1.19 .91
ATP .88 .77 .91 .59 .43 .75 .93
KLA/ATP .26 .26 .30 .28 .80 1.06 .97
Cd14
KLA  ATP  ATP+KLA
 NM_009841 CD14 antigen (Cd14), mRNA [NM_009841] KLA 2.35 2.68 2.54 2.21 2.39 1.52 1.57
ATP 1.44 2.28 2.82 3.98 6.68 16.14 6.92
KLA/ATP 2.92 3.79 3.96 5.12 5.29 10.42 11.50
Cd209a
KLA  ATP  ATP+KLA
 NM_133238 CD209a antigen (Cd209a), mRNA [NM_133238] KLA .97 .98 1.09 .99 1.01 .96 1.02
ATP .97 1.00 1.12 .94 .96 .99 .89
KLA/ATP .99 1.03 1.08 1.01 1.01 1.08 1.01
Cd209b
KLA  ATP  ATP+KLA
 NM_001037800 CD209b antigen (Cd209b), transcript variant 2, mRNA [NM_001037800] KLA 1.00 1.01 1.01 1.03 1.00 .97 1.04
ATP 1.00 1.03 1.02 .95 1.00 .91 .94
KLA/ATP .94 1.00 .96 .97 .98 1.02 1.05
Cd209c
KLA  ATP  ATP+KLA
 NM_130903 CD209c antigen (Cd209c), mRNA [NM_130903] KLA 1.02 1.03 1.02 1.01 1.09 1.02 1.00
ATP .97 1.05 1.02 1.02 1.02 1.03 1.04
KLA/ATP .98 .95 1.09 1.02 .99 1.04 .99
Cd209d
KLA  ATP  ATP+KLA
 NM_130904 CD209d antigen (Cd209d), mRNA [NM_130904] KLA .96 1.00 1.03 1.04 .95 .97 1.01
ATP .99 .97 .97 1.02 .97 .95 1.05
KLA/ATP 1.04 1.08 .99 1.02 .95 .99 1.05
Cd209e
KLA  ATP  ATP+KLA
 NM_130905 CD209e antigen (Cd209e), mRNA [NM_130905] KLA 1.02 1.05 1.01 1.01 1.00 1.03 .96
ATP .96 .94 1.03 1.10 1.01 1.03 1.09
KLA/ATP .99 .99 .95 1.03 1.05 1.01 1.00
Cd74
KLA  ATP  ATP+KLA
 NM_001042605 CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated) (Cd74), transcript variant 1, mRNA [NM_001042605] KLA 1.55 1.72 1.80 1.45 1.77 1.60 2.05
ATP 1.24 1.54 1.11 2.35 1.58 1.16 2.23
KLA/ATP 2.13 2.19 1.12 3.06 1.61 1.61 4.15
Cebpb
KLA  ATP  ATP+KLA
 NM_009883 CCAAT/enhancer binding protein (C/EBP), beta (Cebpb), mRNA [NM_009883] KLA 4.23 5.09 5.13 5.70 7.11 6.62 5.94
ATP 1.52 2.60 4.55 14.19 16.93 10.86 3.06
KLA/ATP 4.97 7.06 8.37 18.16 20.66 8.78 8.37
Cebpb
KLA  ATP  ATP+KLA
 X62600 gb|M.musculus mRNA for C/EBP beta. [X62600] KLA 4.28 4.63 4.35 7.32 6.89 7.11 6.82
ATP 1.41 2.03 5.60 13.16 23.55 15.76 3.02
KLA/ATP 4.35 6.27 11.70 17.46 25.69 11.34 9.42
Cebpg
KLA  ATP  ATP+KLA
 NM_009884 CCAAT/enhancer binding protein (C/EBP), gamma (Cebpg), mRNA [NM_009884] KLA .53 .53 .52 .61 .74 .96 1.08
ATP .96 .97 .93 .86 1.17 .81 1.27
KLA/ATP .55 .52 .54 .58 .88 .74 1.40
Ciita
KLA  ATP  ATP+KLA
 NM_007575 class II transactivator (Ciita), mRNA [NM_007575] KLA 2.13 2.12 2.35 2.22 1.91 1.44 1.12
ATP 1.04 1.04 1.17 1.17 1.61 1.15 1.21
KLA/ATP 2.23 2.44 1.88 1.76 1.64 1.14 1.52
Clec4e
KLA  ATP  ATP+KLA
 NM_019948 C-type lectin domain family 4, member e (Clec4e), mRNA [NM_019948] KLA 19.06 17.93 17.68 18.65 18.12 20.89 24.27
ATP .95 1.11 1.68 5.02 14.08 23.37 8.98
KLA/ATP 20.15 18.54 19.93 19.10 18.32 21.04 26.47
Clec7a
KLA  ATP  ATP+KLA
 NM_020008 C-type lectin domain family 7, member a (Clec7a), mRNA [NM_020008] KLA 1.00 1.09 1.13 1.28 1.06 .69 .23
ATP 1.11 1.37 1.80 1.74 2.19 5.15 3.56
KLA/ATP 1.09 1.37 2.08 2.11 2.41 3.22 2.40
Coro1a
KLA  ATP  ATP+KLA
 NM_009898 coronin, actin binding protein 1A (Coro1a), mRNA [NM_009898] KLA .58 .61 .55 .50 .83 1.28 1.13
ATP 1.00 1.04 .46 .53 .33 .20 .74
KLA/ATP .65 .57 .24 .30 .20 .25 .74
Creb1
KLA  ATP  ATP+KLA
 NM_009952 cAMP responsive element binding protein 1 (Creb1), transcript variant B, mRNA [NM_009952] KLA 1.42 1.33 1.16 .99 .83 .97 .92
ATP .92 .91 1.18 1.38 1.51 1.02 .75
KLA/ATP 1.34 1.31 1.49 1.37 1.71 1.05 .93
Crebbp
KLA  ATP  ATP+KLA
 AK048818 0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230072N21 product:hypothetical protein, full insert sequence [AK048818] KLA 1.44 1.19 1.26 1.25 1.25 1.36 1.24
ATP .98 .90 1.04 1.11 1.95 2.72 1.51
KLA/ATP 1.17 1.27 1.45 1.28 1.98 2.80 2.52
Crebbp
KLA  ATP  ATP+KLA
 NM_001025432 CREB binding protein (Crebbp), mRNA [NM_001025432] KLA .97 1.01 .98 1.06 1.05 .99 1.07
ATP 1.07 1.05 .96 1.01 1.15 1.14 1.00
KLA/ATP 1.01 .97 .97 1.00 1.03 1.23 1.13
Crebbp
KLA  ATP  ATP+KLA
 S66385 gb|CREB-binding protein [mice, brain, mRNA Partial, 7326 nt]. [S66385] KLA 1.00 .98 1.08 .98 1.04 1.07 1.08
ATP .99 .98 .99 1.09 1.13 1.08 1.05
KLA/ATP 1.06 1.00 1.05 1.03 1.02 1.14 1.11
Ctsd
KLA  ATP  ATP+KLA
 NM_009983 cathepsin D (Ctsd), mRNA [NM_009983] KLA .67 .69 .72 .56 .62 .52 .79
ATP 1.07 1.19 .71 .88 .77 .60 1.14
KLA/ATP .86 .84 .49 .67 .49 .51 .82
Ctss
KLA  ATP  ATP+KLA
 NM_021281 cathepsin S (Ctss), mRNA [NM_021281] KLA 1.10 1.10 1.12 1.19 1.11 1.43 2.02
ATP .98 .91 1.04 .79 .87 1.01 1.82
KLA/ATP 1.05 .97 1.18 .98 1.12 1.24 2.03
Cycs
KLA  ATP  ATP+KLA
 NM_007808 cytochrome c, somatic (Cycs), nuclear gene encoding mitochondrial protein, mRNA [NM_007808] KLA 2.20 2.21 2.35 2.69 2.62 3.22 2.14
ATP .87 .89 1.31 1.05 1.06 1.20 1.26
KLA/ATP 1.88 2.04 2.86 2.26 2.57 2.45 2.03
Cyct
KLA  ATP  ATP+KLA
 NM_009989 cytochrome c, testis (Cyct), mRNA [NM_009989] KLA .93 1.01 1.00 .99 1.02 1.03 .96
ATP 1.01 .91 1.01 .99 .98 .95 .95
KLA/ATP 1.10 .96 .89 .89 1.10 1.05 .97
Cyp27b1
KLA  ATP  ATP+KLA
 AB006034 mRNA for 25-hydroxyvitamin D3 1alpha-hydroxylase, partial cds. [AB006034] KLA 1.04 .99 .98 .99 .97 .97 1.00
ATP 1.00 .99 .94 .99 1.05 .95 1.00
KLA/ATP 1.02 .97 .99 .99 .97 .92 1.00
Cyp27b1
KLA  ATP  ATP+KLA
 NM_010009 cytochrome P450, family 27, subfamily b, polypeptide 1 (Cyp27b1), nuclear gene encoding mitochondrial protein, mRNA [NM_010009] KLA 1.18 1.18 1.27 1.18 1.24 1.23 1.12
ATP 1.07 .95 1.21 1.13 1.17 1.17 1.03
KLA/ATP 1.13 1.10 1.36 1.27 1.34 1.13 1.06
EG629860
KLA  ATP  ATP+KLA
 M17953 gb|Mouse Ig rearranged H-chain V-region mRNA VJ1 [M17953] KLA .96 1.05 1.03 1.08 1.08 1.02 .98
ATP .97 .99 1.05 1.10 .95 .94 .91
KLA/ATP .96 .94 .97 1.04 .97 1.01 .89
Eea1
KLA  ATP  ATP+KLA
 NM_001001932 early endosome antigen 1 (Eea1), mRNA [NM_001001932] KLA .88 .83 .77 .79 1.02 .99 .86
ATP 1.09 1.19 1.09 1.47 1.83 1.20 .99
KLA/ATP .92 .90 .82 1.05 1.17 1.03 .82
Ep300
KLA  ATP  ATP+KLA
 AK042627 7 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:A730011L11 product:P300 TRANSCRIPTION COACTIVATOR (FRAGMENT) homolog [Mus sp], full insert sequence. [AK042627] KLA 1.02 .95 .92 1.04 1.01 1.00 1.05
ATP 1.06 .89 .88 .89 1.00 .90 1.07
KLA/ATP 1.10 1.02 .87 .91 1.04 .97 .98
Ep300
KLA  ATP  ATP+KLA
 NM_177821 E1A binding protein p300 (Ep300), mRNA [NM_177821] KLA 1.61 1.26 1.57 1.38 1.78 1.41 1.40
ATP 1.34 1.60 1.11 1.08 1.16 1.05 1.15
KLA/ATP 1.86 1.94 1.18 1.56 1.71 1.42 2.05
Fadd
KLA  ATP  ATP+KLA
 NM_010175 Fas (TNFRSF6)-associated via death domain (Fadd), mRNA [NM_010175] KLA .54 .54 .59 .64 .80 .97 1.16
ATP 1.05 1.09 1.03 1.65 1.18 .78 1.61
KLA/ATP .56 .56 .53 .78 .78 .82 1.34
Fcer1g
KLA  ATP  ATP+KLA
 J05020 gb|Mouse mast cell high affinity IgE receptor (Fc-epsilon-RI) gamma subunit mRNA, complete cds. [J05020] KLA 1.41 1.43 1.53 1.61 1.91 2.07 2.49
ATP 1.13 1.21 .88 1.25 1.06 .92 1.45
KLA/ATP 1.64 1.64 1.25 1.84 1.45 1.39 2.32
Fcer1g
KLA  ATP  ATP+KLA
 NM_010185 Fc receptor, IgE, high affinity I, gamma polypeptide (Fcer1g), mRNA [NM_010185] KLA 1.49 1.54 1.48 1.62 2.18 2.06 2.35
ATP 1.10 1.16 .78 1.00 .90 .98 1.18
KLA/ATP 1.48 1.67 1.26 1.71 1.33 1.40 2.13
Fcgr1
KLA  ATP  ATP+KLA
 AF143181 strain AB/H (Biozzi) high affinity immunoglobulin gamma Fc receptor I (Fcgr1) mRNA, Fcgr1-d allele, complete cds. [AF143181] KLA 4.27 4.21 5.59 6.14 8.13 9.76 10.98
ATP 1.23 1.12 1.08 1.36 1.09 2.09 11.81
KLA/ATP 4.56 4.93 4.95 5.88 6.66 9.64 23.09
Fcgr1
KLA  ATP  ATP+KLA
 NM_010186 Fc receptor, IgG, high affinity I (Fcgr1), mRNA [NM_010186] KLA 4.31 4.37 4.70 5.97 6.59 10.06 8.67
ATP 1.01 .88 1.16 .89 .90 2.15 9.23
KLA/ATP 4.01 4.10 5.52 4.54 6.31 9.24 15.83
Fcgr2b
KLA  ATP  ATP+KLA
 NM_001077189 Fc receptor, IgG, low affinity IIb (Fcgr2b), transcript variant 1, mRNA [NM_001077189] KLA 16.93 17.57 21.75 27.43 34.13 31.88 5.70
ATP 1.11 1.09 1.17 1.46 2.81 11.26 1.92
KLA/ATP 16.51 17.91 23.67 29.22 22.67 25.33 9.54
Fcgr2b
KLA  ATP  ATP+KLA
 NM_010187 Fc receptor, IgG, low affinity IIb (Fcgr2b), transcript variant 2, mRNA [NM_010187] KLA 11.41 11.67 14.06 15.47 17.28 18.63 4.69
ATP 1.05 1.06 1.18 1.57 2.27 8.97 2.10
KLA/ATP 10.98 12.01 15.03 18.38 15.15 16.00 8.33
Fcgr3
KLA  ATP  ATP+KLA
 NM_010188 Fc receptor, IgG, low affinity III (Fcgr3), mRNA [NM_010188] KLA 1.35 1.47 1.87 1.77 2.39 2.34 1.13
ATP 1.04 1.10 .99 1.14 1.01 1.55 1.90
KLA/ATP 1.50 1.53 1.53 1.99 1.61 2.38 2.69
Fcgr4
KLA  ATP  ATP+KLA
 NM_144559 Fc receptor, IgG, low affinity IV (Fcgr4), mRNA [NM_144559] KLA 9.03 8.68 9.82 11.51 11.12 13.01 7.95
ATP 1.04 .95 1.22 1.43 1.17 2.80 4.48
KLA/ATP 8.63 8.84 11.99 11.84 12.40 13.56 12.31
H2-Aa
KLA  ATP  ATP+KLA
 NM_010378 histocompatibility 2, class II antigen A, alpha (H2-Aa), mRNA [NM_010378] KLA 1.43 1.59 1.68 1.50 1.62 1.89 1.64
ATP 1.07 1.15 1.27 1.90 1.92 1.77 1.55
KLA/ATP 1.62 1.81 1.74 2.29 1.89 1.92 2.19
H2-Ab1
KLA  ATP  ATP+KLA
 BC010322 histocompatibility 2, class II antigen A, beta 1, mRNA (cDNA clone MGC:6297 IMAGE:2651058), complete cds [BC010322] KLA 1.73 1.76 1.77 1.55 1.95 2.10 2.27
ATP 1.03 1.18 1.32 1.99 1.79 1.56 1.61
KLA/ATP 1.70 2.01 1.74 2.52 1.58 2.01 2.75
H2-Ab1
KLA  ATP  ATP+KLA
 NM_207105 histocompatibility 2, class II antigen A, beta 1 (H2-Ab1), mRNA [NM_207105] KLA 2.02 2.15 2.07 2.09 2.32 2.78 3.08
ATP 1.11 1.20 1.42 2.33 2.33 2.25 1.87
KLA/ATP 2.11 2.32 2.52 3.62 2.67 2.96 5.04
H2-DMa
KLA  ATP  ATP+KLA
 NM_010386 histocompatibility 2, class II, locus DMa (H2-DMa), mRNA [NM_010386] KLA 1.49 1.50 1.65 1.65 1.91 2.23 1.69
ATP 1.04 1.12 1.26 1.67 1.24 .99 1.32
KLA/ATP 1.58 1.68 1.70 2.02 1.37 1.35 1.90
H2-DMb1
KLA  ATP  ATP+KLA
 NM_010387 histocompatibility 2, class II, locus Mb1 (H2-DMb1), mRNA [NM_010387] KLA 1.06 1.14 1.08 1.13 1.24 1.41 1.37
ATP 1.01 1.02 1.09 1.14 .92 .73 1.36
KLA/ATP 1.13 1.05 1.21 1.17 .98 .83 1.41
H2-DMb2
KLA  ATP  ATP+KLA
 NM_010388 histocompatibility 2, class II, locus Mb2 (H2-DMb2), mRNA [NM_010388] KLA 1.00 1.04 .93 .95 .96 .95 1.03
ATP 1.06 1.04 .94 .92 .97 .95 1.00
KLA/ATP .90 .94 .99 .94 .90 .96 .92
H2-Eb1
KLA  ATP  ATP+KLA
 X52641 gb|Mouse mRNA for I-A beta NOD. [X52641] KLA 1.94 2.06 1.94 1.87 1.96 2.18 1.76
ATP 1.11 1.20 1.53 2.70 3.02 2.91 1.40
KLA/ATP 2.09 2.11 2.26 3.55 2.76 3.05 3.05
H2-Oa
KLA  ATP  ATP+KLA
 NM_008206 histocompatibility 2, O region alpha locus (H2-Oa), mRNA [NM_008206] KLA 1.22 1.32 1.37 1.33 1.31 1.26 1.53
ATP 1.02 1.05 1.16 1.21 1.12 1.07 1.16
KLA/ATP 1.32 1.34 1.31 1.34 1.25 1.35 2.78
H2-Ob
KLA  ATP  ATP+KLA
 NM_010389 histocompatibility 2, O region beta locus (H2-Ob), mRNA [NM_010389] KLA 1.05 1.07 1.01 .96 1.10 1.02 1.00
ATP 1.04 .99 1.00 1.03 .94 1.07 .94
KLA/ATP 1.02 .97 1.06 1.08 1.00 .96 1.05
Hspa9
KLA  ATP  ATP+KLA
 NM_010481 heat shock protein 9 (Hspa9), nuclear gene encoding mitochondrial protein, mRNA [NM_010481] KLA .74 .80 .73 .57 .53 .59 1.24
ATP .96 1.07 1.02 .99 1.38 1.08 .84
KLA/ATP .78 .84 .70 .69 .70 .61 .54
Hspd1
KLA  ATP  ATP+KLA
 NM_010477 heat shock protein 1 (chaperonin) (Hspd1), nuclear gene encoding mitochondrial protein, mRNA [NM_010477] KLA .86 .89 .76 .67 .65 .60 .91
ATP 1.12 1.15 .98 .92 .91 .71 .64
KLA/ATP .86 .97 .82 .74 .56 .38 .34
Ifna12
KLA  ATP  ATP+KLA
 NM_177361 interferon alpha 12 (Ifna12), mRNA [NM_177361] KLA 1.25 1.26 1.34 1.16 1.06 1.10 1.09
ATP 1.01 .97 1.07 1.09 1.17 1.20 1.07
KLA/ATP 1.12 1.29 1.72 1.54 1.59 1.56 1.05
Ifna13
KLA  ATP  ATP+KLA
 NM_177347 interferon alpha 13 (Ifna13), mRNA [NM_177347] KLA 1.32 1.27 1.26 1.34 1.15 1.24 1.20
ATP .95 1.08 1.29 1.79 1.41 1.22 1.08
KLA/ATP 1.36 1.35 2.04 2.81 2.07 1.44 1.19
Ifna2
KLA  ATP  ATP+KLA
 K01411 gb|Mouse alpha-interferon (MuIFN-alpha), 3 cds & untranslated mRNA [K01411] KLA 1.02 1.03 1.10 .96 .93 .99 1.01
ATP 1.02 .98 1.00 .98 1.02 .97 .95
KLA/ATP 1.02 1.04 1.18 1.08 1.13 1.04 1.01
Ifna2
KLA  ATP  ATP+KLA
 NM_010503 interferon alpha 2 (Ifna2), mRNA [NM_010503] KLA 1.08 1.06 1.07 1.06 .98 1.02 1.05
ATP .94 1.06 1.11 1.30 1.24 1.25 1.21
KLA/ATP 1.03 1.20 1.19 1.35 1.52 1.60 1.18
Ifna4
KLA  ATP  ATP+KLA
 NM_010504 interferon alpha 4 (Ifna4), mRNA [NM_010504] KLA .99 1.04 1.05 .97 1.00 .96 .99
ATP 1.01 .96 .98 1.01 1.00 1.00 .97
KLA/ATP 1.10 1.09 1.05 1.04 1.01 .97 1.01
Ifna5
KLA  ATP  ATP+KLA
 NM_010505 interferon alpha 5 (Ifna5), mRNA [NM_010505] KLA 1.15 1.23 1.51 1.26 1.03 1.06 1.05
ATP .99 .94 1.11 1.00 1.09 1.07 1.03
KLA/ATP 1.12 1.29 1.46 1.47 1.24 1.32 1.03
Ifna9
KLA  ATP  ATP+KLA
 NM_010507 interferon alpha 9 (Ifna9), mRNA [NM_010507] KLA 1.05 1.09 1.20 1.06 1.08 1.06 1.02
ATP .99 1.08 1.18 1.21 1.09 .99 .97
KLA/ATP 1.09 1.23 1.19 1.24 1.18 1.16 1.04
Ifnab
KLA  ATP  ATP+KLA
 BC116864 interferon alpha B, mRNA (cDNA clone MGC:151241 IMAGE:40126183), complete cds [BC116864] KLA 1.20 1.33 1.29 1.30 1.20 1.20 1.08
ATP .99 .99 1.00 1.25 1.13 1.19 1.04
KLA/ATP 1.30 1.39 1.44 1.48 1.49 1.54 1.22
Ifnb1
KLA  ATP  ATP+KLA
 NM_010510 interferon beta 1, fibroblast (Ifnb1), mRNA [NM_010510] KLA 49.82 46.57 34.05 16.05 5.94 7.31 8.49
ATP .99 1.02 1.89 4.78 6.31 4.44 1.79
KLA/ATP 49.22 61.83 134.08 144.05 110.96 31.78 11.24
Ifng
KLA  ATP  ATP+KLA
 NM_008337 interferon gamma (Ifng), mRNA [NM_008337] KLA 1.05 1.02 1.01 1.01 1.01 1.04 1.00
ATP 1.00 1.01 1.01 .98 .97 1.04 1.03
KLA/ATP 1.01 1.01 1.06 1.10 1.24 1.10 1.04
Ifngr1
KLA  ATP  ATP+KLA
 NM_010511 interferon gamma receptor 1 (Ifngr1), mRNA [NM_010511] KLA .81 .60 .37 .35 .34 .39 .54
ATP 1.05 .96 1.15 .97 .80 .67 .45
KLA/ATP .57 .57 .63 .36 .28 .33 .36
Ifngr2
KLA  ATP  ATP+KLA
 NM_008338 interferon gamma receptor 2 (Ifngr2), mRNA [NM_008338] KLA 1.45 1.49 1.74 2.22 3.22 2.42 1.96
ATP 1.11 1.03 .81 .78 1.12 1.28 1.34
KLA/ATP 1.48 1.41 1.17 1.23 1.48 1.89 2.13
Igh-VJ55
8
KLA  ATP  ATP+KLA
 AY547436 immunoglobulin heavy chain VDJ region mRNA, partial cds [AY547436] KLA 1.06 1.05 1.01 .93 1.03 .96 .93
ATP .99 1.00 1.06 .95 .96 1.06 1.05
KLA/ATP .98 .94 1.07 .95 .97 .99 1.02
Igh-VJ55
8
KLA  ATP  ATP+KLA
 CA578712 gb|K0727F04-5N NIA Mouse Hematopoietic Stem Cell (Lin- [CA578712] KLA .99 .94 1.01 1.10 .93 .97 .92
ATP .93 1.04 1.01 .98 1.05 .96 .95
KLA/ATP .99 .95 .95 .98 1.02 .98 .95
Igh-VJ55
8
KLA  ATP  ATP+KLA
 ENSMUST00000103412 ens|Immunoglobulin heavy chain C gene segment [Source:IMGT/GENE_DB;Acc:IGHA] [ENSMUST00000103412] KLA 1.01 .97 1.20 1.01 .98 1.44 1.24
ATP .99 .98 1.07 1.03 1.00 1.01 1.21
KLA/ATP .99 1.02 .96 1.03 .97 1.13 1.30
Igh-VJ55
8
KLA  ATP  ATP+KLA
 ENSMUST00000103413 ens|Immunoglobulin heavy chain C gene segment [Source:IMGT/GENE_DB;Acc:IGHE] [ENSMUST00000103413] KLA 1.00 .99 1.06 1.06 .99 1.03 1.02
ATP 1.08 1.06 1.06 1.06 1.02 1.06 .95
KLA/ATP 1.00 1.04 1.09 1.02 1.06 1.02 .95
Igh-VJ55
8
KLA  ATP  ATP+KLA
 U39781 J558+ IgM heavy chain mRNA, hybridoma clone ME2B7, partial cds. [U39781] KLA .93 .89 .98 .97 1.03 1.00 .94
ATP 1.04 1.02 1.08 .94 .93 .90 .79
KLA/ATP .88 .89 .97 .93 .88 .92 .82
Il10
KLA  ATP  ATP+KLA
 NM_010548 interleukin 10 (Il10), mRNA [NM_010548] KLA 17.59 18.64 22.22 23.06 11.83 8.27 2.07
ATP 1.86 3.22 7.72 20.51 25.86 8.38 1.01
KLA/ATP 17.91 23.49 34.53 34.48 20.98 12.03 8.17
Il10ra
KLA  ATP  ATP+KLA
 NM_008348 interleukin 10 receptor, alpha (Il10ra), mRNA [NM_008348] KLA 4.92 4.49 5.29 3.79 4.00 3.02 1.77
ATP 1.15 1.13 1.19 1.16 2.95 1.73 .80
KLA/ATP 5.70 4.92 6.13 3.01 4.78 3.11 2.37
Il10rb
KLA  ATP  ATP+KLA
 AF440787 C57BL [AF440787] KLA .71 .67 .65 .81 1.20 1.50 1.07
ATP 1.03 1.04 1.01 1.12 .84 .85 1.52
KLA/ATP .67 .68 .70 .82 .92 1.23 1.83
Il10rb
KLA  ATP  ATP+KLA
 AK018347 12 days embryo female ovary cDNA, RIKEN full-length enriched library, clone:6620401D04 product:unclassifiable, full insert sequence. [AK018347] KLA .89 1.00 1.05 1.07 1.29 1.12 .96
ATP .91 .73 1.23 1.43 .98 1.06 .92
KLA/ATP .86 .83 1.13 1.41 1.24 1.11 1.13
Il12a
KLA  ATP  ATP+KLA
 NM_008351 interleukin 12a (Il12a), mRNA [NM_008351] KLA 2.37 2.47 2.17 1.49 1.46 1.12 1.20
ATP 1.01 .97 1.12 1.07 1.02 1.07 1.06
KLA/ATP 2.01 2.76 2.54 1.70 1.08 1.10 1.27
Il12b
KLA  ATP  ATP+KLA
 NM_008352 interleukin 12b (Il12b), mRNA [NM_008352] KLA 194.79 211.32 198.97 173.01 142.24 40.28 3.10
ATP 1.05 1.10 1.59 1.99 2.71 2.72 1.52
KLA/ATP 191.27 223.23 280.10 224.29 183.03 68.43 10.69
Il18
KLA  ATP  ATP+KLA
 NM_008360 interleukin 18 (Il18), mRNA [NM_008360] KLA 12.14 11.96 12.28 12.96 12.23 7.84 2.40
ATP 1.06 .96 1.13 1.04 .92 1.67 2.29
KLA/ATP 11.55 11.63 13.03 9.98 9.08 6.50 6.72
Il1a
KLA  ATP  ATP+KLA
 NM_010554 interleukin 1 alpha (Il1a), mRNA [NM_010554] KLA 32.45 35.22 31.30 20.95 28.57 18.36 19.02
ATP 1.04 1.02 2.21 5.46 11.06 32.07 3.40
KLA/ATP 32.02 41.20 35.12 46.91 28.76 42.72 57.80
Il1b
KLA  ATP  ATP+KLA
 NM_008361 interleukin 1 beta (Il1b), mRNA [NM_008361] KLA 149.78 133.59 100.91 116.58 86.48 89.37 64.72
ATP 3.49 13.96 61.44 70.91 82.12 162.79 28.18
KLA/ATP 130.32 139.00 219.12 148.17 165.44 172.57 146.98
Il23a
KLA  ATP  ATP+KLA
 NM_031252 interleukin 23, alpha subunit p19 (Il23a), mRNA [NM_031252] KLA 1.36 1.46 1.33 1.20 1.05 1.04 1.02
ATP .99 1.01 1.06 1.36 1.25 1.07 1.02
KLA/ATP 1.52 1.62 1.48 1.60 1.23 1.12 1.07
Il6
KLA  ATP  ATP+KLA
 NM_031168 interleukin 6 (Il6), mRNA [NM_031168] KLA 352.99 378.70 276.81 168.47 59.99 18.66 8.27
ATP 1.04 1.08 2.28 3.69 30.40 161.93 2.11
KLA/ATP 334.28 528.66 ###.## 935.86 302.45 355.36 99.65
Irak1
KLA  ATP  ATP+KLA
 NM_008363 interleukin-1 receptor-associated kinase 1 (Irak1), mRNA [NM_008363] KLA .67 .67 .64 .56 .58 .58 .84
ATP 1.02 1.10 .94 1.14 .81 .54 .87
KLA/ATP .72 .72 .57 .67 .51 .43 .62
Irak2
KLA  ATP  ATP+KLA
 NM_172161 interleukin-1 receptor-associated kinase 2 (Irak2), transcript variant 1, mRNA [NM_172161] KLA 8.24 8.89 7.70 6.43 6.61 4.53 3.48
ATP 1.06 1.22 1.26 2.10 4.99 4.55 2.69
KLA/ATP 8.32 9.13 7.57 7.95 5.01 6.84 8.36
Irak4
KLA  ATP  ATP+KLA
 NM_029926 interleukin-1 receptor-associated kinase 4 (Irak4), mRNA [NM_029926] KLA .82 .86 .78 .82 .95 1.21 1.22
ATP 1.02 1.18 .95 1.10 .79 .85 .82
KLA/ATP .86 .89 .77 .90 .78 .96 .88
Itgam
KLA  ATP  ATP+KLA
 NM_001082960 integrin alpha M (Itgam), transcript variant 1, mRNA [NM_001082960] KLA 1.04 1.12 1.14 1.07 1.54 1.80 1.72
ATP 1.17 1.19 .97 1.16 .86 .65 1.33
KLA/ATP 1.19 1.19 .94 1.06 .64 .59 1.08
Itgam
KLA  ATP  ATP+KLA
 NM_008401 integrin alpha M (Itgam), transcript variant 2, mRNA [NM_008401] KLA 1.20 1.16 1.21 1.34 1.59 1.79 1.64
ATP 1.15 1.16 .94 1.20 1.00 .78 1.25
KLA/ATP 1.32 1.37 1.29 1.14 .84 .75 1.16
Itgax
KLA  ATP  ATP+KLA
 AK089167 NOD-derived CD11c +ve dendritic cells cDNA, RIKEN full-length enriched library, clone:F630002M04 product:integrin alpha X, full insert sequence. [AK089167] KLA 1.07 1.10 1.11 1.08 1.01 1.08 .92
ATP .97 .99 1.09 1.23 1.01 1.00 1.25
KLA/ATP 1.05 1.11 1.09 1.13 1.05 1.01 1.02
Itgax
KLA  ATP  ATP+KLA
 NM_021334 integrin alpha X (Itgax), mRNA [NM_021334] KLA .89 .92 .92 .89 .75 .52 .28
ATP 1.03 1.02 1.18 1.16 1.01 .74 .49
KLA/ATP .97 1.01 1.13 1.10 .86 .64 .42
Itgb2
KLA  ATP  ATP+KLA
 NM_008404 integrin beta 2 (Itgb2), mRNA [NM_008404] KLA .78 .78 .97 .74 1.04 .94 1.14
ATP 1.24 1.23 .79 .95 1.12 .84 1.10
KLA/ATP .99 1.01 .60 .83 .78 .73 .99
Itgb2l
KLA  ATP  ATP+KLA
 NM_008405 integrin beta 2-like (Itgb2l), mRNA [NM_008405] KLA .87 .98 .98 1.00 1.05 1.07 1.10
ATP 1.24 1.23 1.13 1.14 1.29 1.05 1.05
KLA/ATP 1.02 1.08 1.08 1.06 .98 .93 .95
Jak1
KLA  ATP  ATP+KLA
 AK029232 0 day neonate head cDNA, RIKEN full-length enriched library, clone:4831433J01 product:Janus kinase 1, full insert sequence. [AK029232] KLA 1.25 1.13 1.19 1.31 1.24 1.17 1.14
ATP 1.01 1.11 .96 1.38 1.06 1.26 1.05
KLA/ATP 1.19 1.29 1.27 1.59 1.18 1.38 1.24
Jak1
KLA  ATP  ATP+KLA
 NM_146145 Janus kinase 1 (Jak1), mRNA [NM_146145] KLA 1.71 1.75 1.79 1.81 1.72 1.37 1.21
ATP 1.03 1.01 .75 1.04 1.32 1.90 1.14
KLA/ATP 1.84 1.73 1.49 2.07 2.01 1.83 1.68
Jak2
KLA  ATP  ATP+KLA
 NM_008413 Janus kinase 2 (Jak2), transcript variant 1, mRNA [NM_008413] KLA 14.86 15.05 15.42 14.15 11.46 8.81 5.47
ATP .99 1.06 1.09 1.43 2.83 4.71 1.62
KLA/ATP 13.77 14.74 14.94 12.97 7.53 9.34 9.17
Ksr1
KLA  ATP  ATP+KLA
 NM_013571 kinase suppressor of ras 1 (Ksr1), mRNA [NM_013571] KLA .95 1.00 1.06 1.09 .98 1.12 1.03
ATP 1.01 1.03 1.14 1.05 1.06 1.24 1.21
KLA/ATP 1.02 1.00 1.07 .99 .98 1.09 1.21
Lamp1
KLA  ATP  ATP+KLA
 NM_010684 lysosomal-associated membrane protein 1 (Lamp1), mRNA [NM_010684] KLA .88 .89 .92 .83 .83 .86 1.10
ATP .98 1.02 .91 .87 .92 .94 1.31
KLA/ATP .88 .91 .81 .80 .78 .83 1.21
Lamp2
KLA  ATP  ATP+KLA
 NM_001017959 lysosomal-associated membrane protein 2 (Lamp2), transcript variant 1, mRNA [NM_001017959] KLA 1.14 1.12 1.25 1.30 1.21 1.30 1.12
ATP .98 .91 1.17 1.00 .91 1.00 .83
KLA/ATP 1.08 1.05 1.33 1.13 1.17 1.45 1.29
Lamp2
KLA  ATP  ATP+KLA
 NM_010685 lysosomal-associated membrane protein 2 (Lamp2), transcript variant 2, mRNA [NM_010685] KLA 1.28 1.27 1.42 1.54 1.36 1.50 1.14
ATP 1.03 .95 1.18 .77 .86 .80 .71
KLA/ATP 1.27 1.23 1.50 .91 1.00 .95 1.21
Lbp
KLA  ATP  ATP+KLA
 NM_008489 lipopolysaccharide binding protein (Lbp), mRNA [NM_008489] KLA 1.01 1.01 .94 1.02 1.03 1.06 1.00
ATP 1.00 .99 .96 1.03 .91 .89 .84
KLA/ATP .98 .96 1.01 .93 1.00 .95 .83
Lsp1
KLA  ATP  ATP+KLA
 NM_019391 lymphocyte specific 1 (Lsp1), mRNA [NM_019391] KLA 1.10 1.26 1.36 .96 1.03 .65 .16
ATP 1.06 1.20 1.04 1.57 1.11 .45 .24
KLA/ATP 1.35 1.37 .97 1.71 1.02 .70 .26
Malt1
KLA  ATP  ATP+KLA
 AK172081 activated spleen cDNA, RIKEN full-length enriched library, clone:F830035G05 product:unclassifiable, full insert sequence [AK172081] KLA 8.85 8.52 6.90 6.44 8.01 3.16 3.02
ATP 1.37 1.55 2.57 6.23 6.73 5.82 1.27
KLA/ATP 9.01 10.69 14.85 12.51 4.33 4.50 6.89
Malt1
KLA  ATP  ATP+KLA
 NM_172833 mucosa associated lymphoid tissue lymphoma translocation gene 1 (Malt1), mRNA [NM_172833] KLA 17.74 16.14 15.00 9.66 9.87 4.22 3.54
ATP 1.20 1.19 2.20 5.12 10.20 8.16 1.25
KLA/ATP 19.07 18.41 21.75 20.07 13.32 7.72 8.40
Mapk1
KLA  ATP  ATP+KLA
 NM_001038663 mitogen-activated protein kinase 1 (Mapk1), transcript variant 2, mRNA [NM_001038663] KLA .97 1.03 .93 .86 .79 1.01 1.04
ATP .96 1.18 1.01 1.13 .84 1.04 1.16
KLA/ATP .99 .99 .84 .87 .63 .96 1.26
Mapk1
KLA  ATP  ATP+KLA
 NM_011949 mitogen-activated protein kinase 1 (Mapk1), transcript variant 1, mRNA [NM_011949] KLA .88 .80 .80 .73 .75 .76 .65
ATP .97 .96 1.06 .88 .90 .68 .48
KLA/ATP .82 .81 .78 .65 .64 .64 .45
Mapk10
KLA  ATP  ATP+KLA
 AK076990 adult male testis cDNA, RIKEN full-length enriched library, clone:4930597C01 product:mitogen activated protein kinase 10, full insert sequence. [AK076990] KLA 1.03 1.05 .98 1.04 .94 .95 1.02
ATP 1.00 .99 1.06 .97 1.01 .96 .99
KLA/ATP 1.07 1.01 .95 1.05 .82 .95 .87
Mapk10
KLA  ATP  ATP+KLA
 NM_009158 mitogen-activated protein kinase 10 (Mapk10), transcript variant 1, mRNA [NM_009158] KLA .95 1.00 .97 1.01 .99 1.01 .95
ATP 1.01 1.02 .98 1.01 1.04 1.01 .99
KLA/ATP 1.05 .99 1.01 .98 .92 .97 .98
Mapk11
KLA  ATP  ATP+KLA
 NM_011161 mitogen-activated protein kinase 11 (Mapk11), mRNA [NM_011161] KLA 1.28 1.30 1.41 1.46 1.58 1.29 .98
ATP .96 .95 .89 .82 .79 1.09 .85
KLA/ATP 1.44 1.42 1.32 1.23 1.23 .74 .66
Mapk12
KLA  ATP  ATP+KLA
 NM_013871 mitogen-activated protein kinase 12 (Mapk12), mRNA [NM_013871] KLA .94 .86 .87 .81 .77 .68 .49
ATP .97 .83 .92 .90 .86 .90 .51
KLA/ATP .91 .89 .88 .85 1.12 1.14 .53
Mapk13
KLA  ATP  ATP+KLA
 NM_011950 mitogen-activated protein kinase 13 (Mapk13), mRNA [NM_011950] KLA 1.22 1.21 1.35 1.26 1.24 1.13 1.01
ATP 1.08 1.00 1.20 1.20 1.13 1.22 1.39
KLA/ATP 1.22 1.27 1.30 1.30 1.21 1.11 1.47
Mapk14
KLA  ATP  ATP+KLA
 NM_011951 mitogen-activated protein kinase 14 (Mapk14), mRNA [NM_011951] KLA .70 .70 .62 .54 .67 .88 1.11
ATP 1.03 .98 .87 .69 .48 .78 .66
KLA/ATP .74 .68 .52 .46 .38 .45 .62
Mapk3
KLA  ATP  ATP+KLA
 NM_011952 mitogen-activated protein kinase 3 (Mapk3), mRNA [NM_011952] KLA .81 .85 .88 .72 .79 .73 .90
ATP 1.13 1.30 .92 1.48 1.08 .68 1.03
KLA/ATP 1.01 1.01 .66 1.13 .77 .77 1.16
Mapk8
KLA  ATP  ATP+KLA
 AK162915 adult male spinal cord cDNA, RIKEN full-length enriched library, clone:A330031O19 product:mitogen activated protein kinase 8, full insert sequence [AK162915] KLA .94 .86 .80 .83 .77 .85 .83
ATP 1.08 1.12 .94 .80 .83 .71 .75
KLA/ATP .83 .81 .80 .74 .74 .75 .67
Mapk8
KLA  ATP  ATP+KLA
 AK163829 16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130070A06 product:mitogen activated protein kinase 8, full insert sequence [AK163829] KLA .65 .61 .66 .70 .90 1.02 1.03
ATP .99 .94 1.68 1.44 1.75 1.84 1.10
KLA/ATP .63 .67 1.11 1.00 2.01 1.68 1.15
Mapk8
KLA  ATP  ATP+KLA
 NM_016700 mitogen-activated protein kinase 8 (Mapk8), mRNA [NM_016700] KLA .96 1.00 .94 .96 .94 .99 1.04
ATP 1.01 1.05 1.01 .99 1.03 .98 1.02
KLA/ATP .96 .97 .96 .97 .93 .94 .96
Mapk9
KLA  ATP  ATP+KLA
 NM_016961 mitogen-activated protein kinase 9 (Mapk9), transcript variant 2, mRNA [NM_016961] KLA 1.28 1.37 1.59 1.60 1.61 1.43 1.38
ATP 1.03 .99 .74 .71 .79 1.20 1.01
KLA/ATP 1.53 1.30 1.07 .99 .83 1.10 1.40
Mapk9
KLA  ATP  ATP+KLA
 NM_207692 mitogen-activated protein kinase 9 (Mapk9), transcript variant 1, mRNA [NM_207692] KLA 1.39 1.53 1.69 1.69 1.55 1.44 1.51
ATP .95 .92 .75 .85 .70 1.46 1.17
KLA/ATP 1.37 1.35 .99 1.18 .91 1.22 1.62
Mm.13153
0
KLA  ATP  ATP+KLA
 161086915 Unknown KLA 1.00 1.07 1.14 1.08 .97 1.00 .93
ATP 1.04 .99 1.00 .95 .99 1.02 .90
KLA/ATP 1.08 1.18 1.14 1.16 1.04 1.06 1.08
Mm.17516
3
KLA  ATP  ATP+KLA
 83699405 Unknown KLA .98 .99 1.01 .95 .99 1.06 .96
ATP 1.03 1.00 1.07 1.02 1.02 .98 .97
KLA/ATP 1.01 1.08 1.03 1.00 1.03 .93 .97
Mm.22263
3
KLA  ATP  ATP+KLA
 83977453 Unknown KLA 16.47 14.58 14.05 17.89 13.04 11.85 6.01
ATP 1.14 .97 1.34 1.39 4.26 11.88 2.10
KLA/ATP 16.16 16.61 15.95 7.90 9.42 13.83 13.56
Mm.23400
3
KLA  ATP  ATP+KLA
 133893277 Unknown KLA 1.08 1.14 1.11 .89 .93 .66 .18
ATP 1.06 1.25 .95 1.49 1.04 .46 .24
KLA/ATP 1.18 1.20 .84 1.41 .92 .69 .28
Mm.24508
4
KLA  ATP  ATP+KLA
 144227202 Unknown KLA 1.06 1.07 1.19 1.42 1.09 .83 .67
ATP .99 1.02 1.16 1.40 1.51 1.67 1.61
KLA/ATP 1.04 1.06 1.35 1.56 1.65 1.92 2.49
Mm.24936
4
KLA  ATP  ATP+KLA
 133892283 Unknown KLA 1.42 1.41 1.61 2.14 2.88 2.49 2.03
ATP .98 .98 .76 .77 1.09 1.23 1.28
KLA/ATP 1.32 1.32 1.07 1.12 1.38 1.85 1.95
Mm.27970
KLA  ATP  ATP+KLA
 13994135 Unknown KLA 1.06 1.11 1.16 1.07 1.11 1.08 .95
ATP 1.02 1.09 1.05 1.05 .94 1.16 1.32
KLA/ATP 1.10 1.19 1.11 1.04 1.08 1.02 1.33
Mm.33138
9
KLA  ATP  ATP+KLA
 158508469 Unknown KLA .80 .79 .81 .82 .72 .64 .50
ATP .95 .85 .56 .48 .30 .33 .46
KLA/ATP .71 .64 .50 .41 .33 .32 .42
Mm.37708
7
KLA  ATP  ATP+KLA
 158631169 Unknown KLA .98 .98 1.06 1.06 .91 .97 1.04
ATP 1.00 1.07 1.01 1.06 1.09 .99 1.02
KLA/ATP 1.08 1.06 1.16 1.11 1.16 1.12 1.04
Mm.38049
KLA  ATP  ATP+KLA
 118130391 Unknown KLA .67 .65 .73 .92 .63 .81 .76
ATP .93 .92 1.08 .54 .45 1.48 1.56
KLA/ATP .57 .65 .98 .67 .44 .78 1.16
Mm.4387
KLA  ATP  ATP+KLA
 133892666 Unknown KLA .85 .87 .85 .89 .77 .91 1.18
ATP 1.01 1.01 .87 1.07 .75 .86 .93
KLA/ATP .88 .86 .77 .81 .72 .91 .84
Mm.43973
7
KLA  ATP  ATP+KLA
 110624769 Unknown KLA 1.37 1.42 1.33 1.29 1.33 1.39 1.52
ATP 1.00 1.08 1.15 1.51 1.42 1.32 1.59
KLA/ATP 1.44 1.48 1.35 1.93 1.62 1.67 2.56
Mm.44889
KLA  ATP  ATP+KLA
 157057165 Unknown KLA 1.20 1.25 1.45 1.49 1.63 1.70 1.66
ATP 1.00 1.03 1.03 1.00 1.12 1.06 1.23
KLA/ATP 1.25 1.15 1.16 1.16 1.15 1.41 1.71
Mm.46002
4
KLA  ATP  ATP+KLA
 38348245 Unknown KLA 1.22 1.25 1.25 1.19 1.22 1.47 1.14
ATP 1.03 .94 1.01 1.01 2.67 2.31 1.37
KLA/ATP 1.35 1.19 1.27 1.22 1.99 1.83 1.45
Mm.47526
5
KLA  ATP  ATP+KLA
 145046272 Unknown KLA 1.05 .97 .80 .91 .84 .88 .82
ATP .96 .81 1.14 .73 .64 1.00 .85
KLA/ATP .91 .89 .98 .66 .67 .78 .64
Mm.5092
KLA  ATP  ATP+KLA
 6679364 Unknown KLA 1.66 1.91 1.84 1.77 1.67 2.24 1.50
ATP 1.03 1.01 1.08 1.00 .91 .86 .86
KLA/ATP 1.74 1.72 1.71 1.43 1.12 1.07 1.15
Mm.5126
KLA  ATP  ATP+KLA
 158508678 Unknown KLA .70 .71 .73 .79 .87 1.11 1.25
ATP 1.22 1.37 1.08 1.54 1.38 1.01 1.26
KLA/ATP .85 .83 .75 .90 1.12 .96 1.17
Mm.57127
KLA  ATP  ATP+KLA
 117168292 Unknown KLA 1.20 1.25 1.28 1.18 1.14 1.13 1.12
ATP .98 .95 1.11 1.06 1.05 1.05 1.09
KLA/ATP 1.22 1.24 1.48 1.55 1.40 1.21 1.07
Mm.874
KLA  ATP  ATP+KLA
 6754317 Unknown KLA 24.98 24.87 26.43 39.61 12.88 8.64 1.63
ATP 1.97 3.50 11.05 28.47 38.30 10.44 .65
KLA/ATP 23.45 29.37 58.52 51.77 30.64 14.61 8.63
Mrc1
KLA  ATP  ATP+KLA
 NM_008625 mannose receptor, C type 1 (Mrc1), mRNA [NM_008625] KLA .57 .50 .60 .48 .28 .10 .01
ATP 1.12 1.05 1.03 .65 .57 .31 .23
KLA/ATP .57 .57 .58 .36 .21 .14 .04
Mrc2
KLA  ATP  ATP+KLA
 NM_008626 mannose receptor, C type 2 (Mrc2), mRNA [NM_008626] KLA 1.02 1.01 1.07 1.08 1.00 1.00 1.04
ATP .99 .93 1.08 1.04 1.03 .95 1.12
KLA/ATP 1.03 1.04 1.04 1.13 1.15 1.08 .98
Myd88
KLA  ATP  ATP+KLA
 NM_010851 myeloid differentiation primary response gene 88 (Myd88), mRNA [NM_010851] KLA 3.35 3.51 3.91 4.13 4.13 3.62 2.53
ATP .99 .96 .79 .75 .93 2.15 1.60
KLA/ATP 3.37 3.52 3.52 3.48 2.81 3.03 3.33
Nfkb1
KLA  ATP  ATP+KLA
 BC050841 nuclear factor of kappa light chain gene enhancer in B-cells 1, p105, mRNA (cDNA clone IMAGE:6392793), complete cds. [BC050841] KLA 5.81 4.96 4.77 3.21 3.37 2.00 1.71
ATP 1.39 1.52 3.25 12.63 13.64 4.80 1.08
KLA/ATP 7.21 8.69 19.53 23.93 11.70 2.85 2.01
Nfkb1
KLA  ATP  ATP+KLA
 M57999 gb|Mouse transcription factor NF-kappa-B DNA binding subunit mRNA, complete cds. [M57999] KLA 8.55 7.87 7.35 6.13 3.51 1.85 1.38
ATP .98 .96 1.21 3.06 5.29 4.67 .69
KLA/ATP 7.32 7.20 8.71 10.82 5.55 2.77 1.54
Nfya
KLA  ATP  ATP+KLA
 NM_001110832 nuclear transcription factor-Y alpha (Nfya), transcript variant 1, mRNA [NM_001110832] KLA .66 .63 .69 .67 .89 .92 .87
ATP 1.07 1.02 .41 .65 1.30 1.20 .84
KLA/ATP .68 .70 .36 .54 .82 1.19 .82
Nfya
KLA  ATP  ATP+KLA
 NM_010913 nuclear transcription factor-Y alpha (Nfya), transcript variant 2, mRNA [NM_010913] KLA 1.07 1.05 1.08 1.06 1.04 1.35 1.03
ATP .94 .92 .49 .66 1.31 1.93 1.49
KLA/ATP 1.00 .96 .71 .75 .92 1.62 1.55
Nfyb
KLA  ATP  ATP+KLA
 NM_010914 nuclear transcription factor-Y beta (Nfyb), mRNA [NM_010914] KLA 1.38 1.22 1.12 1.30 1.07 .91 .68
ATP 1.09 1.01 .98 .89 .96 1.16 .64
KLA/ATP 1.17 1.21 1.52 1.18 .95 .82 .77
Nfyc
KLA  ATP  ATP+KLA
 NM_008692 nuclear transcription factor-Y gamma (Nfyc), transcript variant 1, mRNA [NM_008692] KLA 1.09 1.19 1.18 1.12 1.17 1.29 1.27
ATP .98 1.10 1.10 1.45 1.36 1.65 1.29
KLA/ATP 1.15 1.17 1.07 1.40 1.20 1.87 1.49
Nod2
KLA  ATP  ATP+KLA
 NM_145857 nucleotide-binding oligomerization domain containing 2 (Nod2), mRNA [NM_145857] KLA 12.51 10.83 11.39 11.89 10.66 9.06 5.17
ATP 1.27 1.10 1.30 1.48 4.63 8.23 2.33
KLA/ATP 12.86 12.85 13.93 8.85 9.30 10.43 11.67
Nos2
KLA  ATP  ATP+KLA
 NM_010927 nitric oxide synthase 2, inducible, macrophage (Nos2), mRNA [NM_010927] KLA 13.50 16.36 25.65 23.25 24.78 15.99 6.48
ATP 1.03 1.03 1.48 1.66 1.65 5.55 1.70
KLA/ATP 16.01 17.41 19.06 25.50 20.84 29.92 29.80
Pik3c3
KLA  ATP  ATP+KLA
 NM_181414 phosphoinositide-3-kinase, class 3 (Pik3c3), mRNA [NM_181414] KLA .85 .82 .90 .91 .99 1.01 .87
ATP .92 1.02 .97 1.08 .60 .82 .87
KLA/ATP .80 .86 .79 .90 .66 .94 .92
Pla2r1
KLA  ATP  ATP+KLA
 NM_008867 phospholipase A2 receptor 1 (Pla2r1), mRNA [NM_008867] KLA 3.76 3.70 4.27 2.95 3.36 4.69 1.93
ATP 1.02 1.09 1.40 1.01 .76 .64 .71
KLA/ATP 3.72 3.92 4.28 2.95 1.60 1.12 1.78
Plk3
KLA  ATP  ATP+KLA
 NM_013807 polo-like kinase 3 (Drosophila) (Plk3), mRNA [NM_013807] KLA .39 .38 .41 .71 1.21 1.27 1.89
ATP 1.53 1.86 3.00 4.82 6.22 3.48 2.14
KLA/ATP .42 .53 1.24 2.64 5.70 4.13 2.71
Ppp3ca
KLA  ATP  ATP+KLA
 NM_008913 protein phosphatase 3, catalytic subunit, alpha isoform (Ppp3ca), mRNA [NM_008913] KLA .76 .85 .81 .85 .73 .70 .52
ATP .96 .78 .55 .46 .31 .33 .48
KLA/ATP .74 .64 .52 .42 .37 .36 .45
Ppp3cb
KLA  ATP  ATP+KLA
 AK135203 12 days embryo male wolffian duct includes surrounding region cDNA, RIKEN full-length enriched library, clone:6720421K10 product:protein phosphatase 3, catalytic subunit, beta isoform, full insert sequence. [AK135203] KLA 1.74 1.57 1.91 1.59 1.47 1.26 1.40
ATP 1.17 1.03 1.30 1.00 .81 .62 1.37
KLA/ATP 1.68 1.70 1.91 1.37 1.09 .47 1.13
Ppp3cb
KLA  ATP  ATP+KLA
 AK171904 activated spleen cDNA, RIKEN full-length enriched library, clone:F830018L06 product:Protein phosphatase 3 catalytic subunit beta3 (EC 3.1.3.16) (Serine [AK171904] KLA 1.29 1.29 1.21 1.15 1.22 1.13 1.28
ATP .90 .86 .80 .98 .94 .73 .92
KLA/ATP 1.06 1.03 .77 1.04 .92 .68 .90
Ppp3cb
KLA  ATP  ATP+KLA
 NM_008914 protein phosphatase 3, catalytic subunit, beta isoform (Ppp3cb), mRNA [NM_008914] KLA 1.21 1.29 1.38 1.24 1.29 1.08 1.23
ATP 1.15 1.31 1.09 1.29 .86 .60 .64
KLA/ATP 1.33 1.40 1.04 1.28 .79 .58 .73
Ppp3cc
KLA  ATP  ATP+KLA
 AK037563 16 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A130026K22 product:unclassifiable, full insert sequence [AK037563] KLA 1.27 1.18 1.21 1.15 1.01 .92 1.36
ATP .96 1.09 1.10 1.03 .85 1.06 1.47
KLA/ATP 1.17 1.24 1.07 1.13 .91 .88 1.36
Ppp3cc
KLA  ATP  ATP+KLA
 NM_008915 protein phosphatase 3, catalytic subunit, gamma isoform (Ppp3cc), mRNA [NM_008915] KLA 1.64 1.81 1.79 1.35 .90 .70 1.31
ATP .90 .90 1.13 .93 .86 1.40 1.60
KLA/ATP 1.45 1.62 1.74 1.47 1.04 1.01 1.31
Ppp3r1
KLA  ATP  ATP+KLA
 NM_024459 protein phosphatase 3, regulatory subunit B, alpha isoform (calcineurin B, type I) (Ppp3r1), mRNA [NM_024459] KLA 1.02 1.17 .93 1.27 1.15 1.30 1.30
ATP .97 .95 .77 .91 .99 1.18 1.10
KLA/ATP 1.12 1.04 .88 1.00 1.10 1.10 1.07
Ppp3r2
KLA  ATP  ATP+KLA
 NM_001004025 protein phosphatase 3, regulatory subunit B, alpha isoform (calcineurin B, type II) (Ppp3r2), mRNA [NM_001004025] KLA 1.03 1.05 1.06 1.08 1.12 1.05 1.04
ATP 1.00 1.02 1.04 1.04 .99 .99 1.01
KLA/ATP 1.04 1.12 1.03 1.09 1.00 .99 1.00
Rab5a
KLA  ATP  ATP+KLA
 AK036011 16 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:9630027A13 product:hypothetical protein, full insert sequence. [AK036011] KLA .98 1.01 .98 .93 1.04 .95 1.02
ATP 1.01 1.02 1.03 .96 1.08 1.04 1.08
KLA/ATP 1.06 1.02 1.02 .92 .99 1.01 1.08
Rab5a
KLA  ATP  ATP+KLA
 NM_025887 RAB5A, member RAS oncogene family (Rab5a), mRNA [NM_025887] KLA 1.88 1.84 2.12 2.01 1.68 1.40 1.18
ATP 1.00 .95 .93 .81 1.10 1.57 1.09
KLA/ATP 1.87 1.86 1.87 1.72 1.71 1.63 1.47
Rab5b
KLA  ATP  ATP+KLA
 AK144551 adult male intestinal mucosa cDNA, RIKEN full-length enriched library, clone:G630095F06 product:RAB5B, member RAS oncogene family, full insert sequence. [AK144551] KLA .84 .93 1.00 .83 1.07 .95 1.19
ATP 1.11 1.01 .75 .84 .97 .93 .88
KLA/ATP .95 .87 .64 .88 .98 .99 .93
Rab5b
KLA  ATP  ATP+KLA
 NM_011229 RAB5B, member RAS oncogene family (Rab5b), mRNA [NM_011229] KLA 1.07 1.13 1.29 1.05 1.14 1.06 1.16
ATP 1.15 1.16 .78 .83 .93 .92 1.15
KLA/ATP 1.22 1.15 .77 .86 .87 .93 1.30
Rab5b
KLA  ATP  ATP+KLA
 NM_177411 RAB5B, member RAS oncogene family (Rab5b), mRNA [NM_177411] KLA 1.38 1.33 1.46 1.18 1.23 1.31 1.30
ATP 1.07 1.32 .83 1.08 .71 1.02 1.34
KLA/ATP 1.57 1.58 .95 1.38 .76 1.04 1.55
Rab5c
KLA  ATP  ATP+KLA
 NM_024456 RAB5C, member RAS oncogene family (Rab5c), mRNA [NM_024456] KLA .96 1.26 1.45 1.13 1.14 1.50 1.17
ATP .95 1.30 1.32 1.01 .98 1.03 1.04
KLA/ATP 1.11 1.37 1.61 1.15 1.00 1.18 1.52
Rab7
KLA  ATP  ATP+KLA
 BI654107 gb|603280186F1 NCI_CGAP_Mam4 Mus musculus cDNA clone IMAGE:5310477 5, mRNA sequence [BI654107] KLA 1.08 1.15 1.33 1.10 1.13 1.26 1.24
ATP .99 1.11 1.08 1.39 1.49 1.69 2.44
KLA/ATP 1.19 1.17 1.12 1.51 1.30 1.77 2.20
Rab7
KLA  ATP  ATP+KLA
 DV064670 gb|NEONATAL_23_D05.x1 FH NEONATAL Mus musculus cDNA clone NEONATAL_23_D05 similar to RAB7 member RAS oncogene family, mRNA sequence [DV064670] KLA 1.01 1.03 1.05 .90 .94 .97 1.09
ATP 1.05 1.16 1.00 1.26 1.36 1.36 1.97
KLA/ATP 1.16 1.08 .77 1.23 1.12 1.41 1.50
Raf1
KLA  ATP  ATP+KLA
 AK036317 16 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:9630056E02 product:v-raf-1 leukemia viral oncogene 1, full insert sequence. [AK036317] KLA 1.47 1.34 1.55 1.29 1.59 1.32 1.46
ATP 1.05 .98 .54 .63 3.32 2.07 1.01
KLA/ATP 1.57 1.33 .79 .96 2.26 1.38 1.35
Raf1
KLA  ATP  ATP+KLA
 NM_029780 v-raf-leukemia viral oncogene 1 (Raf1), mRNA [NM_029780] KLA 1.65 1.64 1.93 1.77 1.77 1.72 1.81
ATP .95 .96 .83 .80 2.22 2.92 1.19
KLA/ATP 1.68 1.64 1.39 1.32 1.85 2.50 2.06
Rela
KLA  ATP  ATP+KLA
 NM_009045 v-rel reticuloendotheliosis viral oncogene homolog A (avian) (Rela), mRNA [NM_009045] KLA 2.05 2.05 2.07 1.75 1.83 1.58 1.33
ATP 1.03 1.08 1.10 1.44 1.61 2.48 1.05
KLA/ATP 2.17 2.27 2.05 2.47 1.93 2.35 2.02
Rfx5
KLA  ATP  ATP+KLA
 NM_017395 regulatory factor X, 5 (influences HLA class II expression) (Rfx5), mRNA [NM_017395] KLA 1.30 1.30 1.30 1.19 1.33 1.22 1.02
ATP 1.08 1.09 1.02 .98 .86 .96 .89
KLA/ATP 1.44 1.38 1.15 1.07 .86 1.07 1.06
Rfxank
KLA  ATP  ATP+KLA
 NM_011266 regulatory factor X-associated ankyrin-containing protein (Rfxank), transcript variant 1, mRNA [NM_011266] KLA .91 .87 .99 1.00 1.17 1.44 1.74
ATP 1.10 1.02 .95 1.29 .98 1.18 2.64
KLA/ATP 1.04 .94 .90 1.01 .93 1.33 3.07
Rfxap
KLA  ATP  ATP+KLA
 NM_133231 regulatory factor X-associated protein (Rfxap), mRNA [NM_133231] KLA .60 .59 .59 .59 .62 .77 .83
ATP .95 .93 .68 .64 1.01 1.02 .96
KLA/ATP .61 .57 .52 .55 .93 1.11 1.03
Rhoa
KLA  ATP  ATP+KLA
 NM_016802 ras homolog gene family, member A (Rhoa), mRNA [NM_016802] KLA .93 1.00 1.07 .97 1.08 1.06 1.02
ATP .93 .88 .49 .61 .63 .78 1.05
KLA/ATP .94 .92 .59 .63 .61 .78 1.12
Ripk2
KLA  ATP  ATP+KLA
 NM_138952 receptor (TNFRSF)-interacting serine-threonine kinase 2 (Ripk2), mRNA [NM_138952] KLA 19.51 18.67 18.82 10.27 5.08 3.42 2.58
ATP 1.05 1.02 1.41 3.66 9.06 6.82 1.68
KLA/ATP 19.33 20.48 15.93 16.05 8.62 9.36 5.23
Sphk1
KLA  ATP  ATP+KLA
 NM_025367 sphingosine kinase 1 (Sphk1), transcript variant 2, mRNA [NM_025367] KLA 2.61 2.50 2.04 1.71 1.19 .91 .74
ATP .94 1.00 2.06 8.09 16.52 12.59 3.53
KLA/ATP 2.64 2.81 3.50 8.13 23.71 16.46 2.22
Sphk2
KLA  ATP  ATP+KLA
 NM_020011 sphingosine kinase 2 (Sphk2), transcript variant 2, mRNA [NM_020011] KLA .64 .74 1.05 1.47 2.15 1.84 1.67
ATP 1.10 1.02 .57 .54 .49 1.29 2.15
KLA/ATP .78 .64 .43 .56 .86 1.90 3.74
Src
KLA  ATP  ATP+KLA
 NM_009271 Rous sarcoma oncogene (Src), transcript variant 1, mRNA [NM_009271] KLA 6.99 7.23 7.54 5.99 5.34 3.39 3.00
ATP 1.02 1.06 1.06 2.08 4.41 5.03 3.97
KLA/ATP 7.44 7.51 5.48 6.24 4.86 5.86 7.90
Stat1
KLA  ATP  ATP+KLA
 NM_009283 signal transducer and activator of transcription 1 (Stat1), mRNA [NM_009283] KLA 2.90 2.72 3.00 3.64 4.58 6.51 5.58
ATP 1.01 .92 .89 .72 .51 2.22 3.07
KLA/ATP 2.73 2.65 2.34 1.95 1.99 4.70 8.66
Syk
KLA  ATP  ATP+KLA
 NM_011518 spleen tyrosine kinase (Syk), mRNA [NM_011518] KLA 2.48 2.59 2.57 2.26 3.29 3.75 3.19
ATP .96 .85 .59 1.01 2.80 3.77 2.11
KLA/ATP 2.56 2.09 1.16 1.35 2.50 4.33 5.10
Tcirg1
KLA  ATP  ATP+KLA
 NM_016921 T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 protein A3 (Tcirg1), mRNA [NM_016921] KLA 1.32 1.42 1.49 1.38 1.94 2.26 1.98
ATP 1.01 1.16 .69 .96 1.24 1.32 2.03
KLA/ATP 1.50 1.58 .90 1.29 1.37 2.08 3.28
Tgfb1
KLA  ATP  ATP+KLA
 NM_011577 transforming growth factor, beta 1 (Tgfb1), mRNA [NM_011577] KLA .87 .89 .90 .70 .83 .77 1.12
ATP 1.20 1.41 .80 1.49 1.11 .93 .99
KLA/ATP 1.10 1.20 .53 1.05 .66 .85 .90
Tgfb2
KLA  ATP  ATP+KLA
 NM_009367 transforming growth factor, beta 2 (Tgfb2), mRNA [NM_009367] KLA 1.01 .91 .98 .98 .92 1.19 .96
ATP .99 1.03 1.00 1.02 .99 1.07 .93
KLA/ATP 1.02 .99 1.03 .98 1.04 1.06 .96
Tgfb3
KLA  ATP  ATP+KLA
 NM_009368 transforming growth factor, beta 3 (Tgfb3), mRNA [NM_009368] KLA .67 .64 .58 .56 .49 .52 .61
ATP .90 .92 1.33 1.08 .78 .65 .74
KLA/ATP .58 .60 .74 .61 .76 1.36 1.51
Tirap
KLA  ATP  ATP+KLA
 AK081514 16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130027E04 product:toll-interleukin 1 receptor (TIR) domain-containing adaptor protein, full insert sequence [AK081514] KLA 1.36 1.33 1.35 1.41 1.36 1.45 1.22
ATP .93 .87 .82 .45 .78 1.93 1.32
KLA/ATP 1.35 1.37 1.30 .83 1.17 1.75 2.10
Tirap
KLA  ATP  ATP+KLA
 NM_054096 toll-interleukin 1 receptor (TIR) domain-containing adaptor protein (Tirap), mRNA [NM_054096] KLA 1.88 1.70 1.69 1.74 1.82 1.69 1.31
ATP 1.12 1.10 .75 .56 1.03 2.52 1.67
KLA/ATP 1.60 1.75 1.69 1.25 1.41 2.27 3.21
Tlr1
KLA  ATP  ATP+KLA
 NM_030682 toll-like receptor 1 (Tlr1), mRNA [NM_030682] KLA 3.57 3.84 4.75 3.97 5.29 4.83 4.46
ATP 1.08 1.06 .78 .61 .46 1.45 2.49
KLA/ATP 3.92 3.96 3.36 3.25 1.78 1.59 4.08
Tlr2
KLA  ATP  ATP+KLA
 NM_011905 toll-like receptor 2 (Tlr2), mRNA [NM_011905] KLA 13.65 11.82 8.87 7.95 4.67 2.78 2.33
ATP 1.06 1.24 2.76 6.28 11.55 13.82 .67
KLA/ATP 13.11 12.91 14.48 13.84 14.18 11.14 2.78
Tlr4
KLA  ATP  ATP+KLA
 NM_021297 toll-like receptor 4 (Tlr4), mRNA [NM_021297] KLA .69 .61 .75 .94 .64 .81 .73
ATP .95 .90 1.12 .56 .47 1.51 1.53
KLA/ATP .57 .62 1.01 .64 .39 .73 1.13
Tlr6
KLA  ATP  ATP+KLA
 NM_011604 toll-like receptor 6 (Tlr6), mRNA [NM_011604] KLA 6.41 6.63 6.53 6.69 4.70 4.27 2.63
ATP 1.04 .95 1.02 .65 1.11 5.02 3.78
KLA/ATP 6.27 6.99 7.49 5.08 4.10 4.69 7.46
Tlr9
KLA  ATP  ATP+KLA
 NM_031178 toll-like receptor 9 (Tlr9), mRNA [NM_031178] KLA 1.08 1.09 1.18 1.15 1.34 1.25 1.16
ATP 1.04 1.05 1.23 1.85 1.41 1.06 1.21
KLA/ATP 1.16 1.17 1.45 1.88 1.67 1.32 1.46
Tnf
KLA  ATP  ATP+KLA
 NM_013693 tumor necrosis factor (Tnf), mRNA [NM_013693] KLA 13.35 12.76 10.71 9.03 10.64 7.39 8.32
ATP 2.01 2.48 8.27 19.20 9.72 4.09 1.49
KLA/ATP 12.72 15.76 12.73 17.34 5.10 3.61 6.07
Tnfrsf1a
KLA  ATP  ATP+KLA
 NM_011609 tumor necrosis factor receptor superfamily, member 1a (Tnfrsf1a), mRNA [NM_011609] KLA 1.74 1.71 1.90 2.16 1.95 1.74 1.16
ATP .95 .83 .55 .41 .41 1.55 1.32
KLA/ATP 1.58 1.49 1.19 1.03 .98 2.02 2.10
Tradd
KLA  ATP  ATP+KLA
 NM_001033161 TNFRSF1A-associated via death domain (Tradd), mRNA [NM_001033161] KLA .77 .71 .82 .89 .89 1.11 1.06
ATP 1.00 .90 1.01 .73 .59 1.34 1.50
KLA/ATP .79 .73 .83 .63 .72 1.11 1.73
Traf6
KLA  ATP  ATP+KLA
 NM_009424 Tnf receptor-associated factor 6 (Traf6), mRNA [NM_009424] KLA 1.19 1.28 1.34 1.20 1.23 1.23 1.28
ATP 1.06 1.12 .92 1.15 2.46 1.84 1.40
KLA/ATP 1.32 1.37 .89 1.16 1.45 1.49 1.46
Vdr
KLA  ATP  ATP+KLA
 NM_009504 vitamin D receptor (Vdr), mRNA [NM_009504] KLA 1.01 1.01 1.12 1.12 1.09 .96 .94
ATP .99 1.03 1.09 1.19 1.25 1.24 1.36
KLA/ATP .99 1.03 1.03 1.28 1.21 1.42 1.76